Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · LeMaitre Vascular (LMAT)

LeMaitre Vascular names Dorian LeBlanc CFO, effective March 10, 2025

Neutral Impact 4 of 5 leadership Written later

LeMaitre Vascular agreed on February 7, 2025 to appoint Dorian LeBlanc as Chief Financial Officer and principal financial officer, effective March 10, 2025. LeBlanc most recently served as CFO of LumiraDx Limited, and later as its Chief Operating Officer, and the filing describes his offer letter terms, including base salary, bonus target, equity awards and severance.

Key points

  • Dorian LeBlanc agreed to terms on February 7, 2025 and takes over as CFO effective March 10, 2025.
  • Starting annual base salary of $565,000, with a discretionary bonus target of $225,000 and an annual equity award of $375,000 vesting over four years.
  • One-time restricted stock unit award valued at $100,000, vesting over four years.
  • If terminated without cause on or before March 10, 2028, severance is $100,000; after that date, it is the greater of two weeks of base salary per full year of service or $225,000.

The filing

CompanyLeMaitre Vascular (LMAT)
Form8-K, current report
Filed with the SECFeb 13, 2025, 9:00 AM ET
Accession number0001437749-25-003679

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 13, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.